Here are five points:
1. NuVasive accounts for 0.3 percent of Quantitative Systematic Strategies’ holdings.
2. The firm has an average rating of “buy” and an average target price of $58.54.
3. The company’s 50-day moving average is $47.93, and its 200-day moving average is $50.81.
4. NuVasive has a 52-week low of $36.81 and a 52-week high of $56.61.
5. The firm has a market capitalization of $1.94 billion.
More articles on devices:
43 spine, orthopedic devices receive FDA 510(k) clearance in January
Foot and ankle market to reach $5.4B in 2020 — 4 insights
Wright Medical Group shares receive average price target of $28.11: 5 things to know
